540 related articles for article (PubMed ID: 15121300)
21. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E
Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794
[TBL] [Abstract][Full Text] [Related]
22. The effect of pertussis whole cell and acellular vaccines on pulmonary immunology in an aerosol challenge model.
Carter CR; Dagg BM; Whitmore KM; Keeble JR; Asokanathan C; Xing D; Walker KB
Cell Immunol; 2004 Jan; 227(1):51-8. PubMed ID: 15051514
[TBL] [Abstract][Full Text] [Related]
23. Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines.
Hale C; Humphreys IR; Hussell T; Bowe F; Clare S; Pickard D; Preston A; Del Giudice G; Dougan G
Vaccine; 2004 Sep; 22(27-28):3595-602. PubMed ID: 15315838
[TBL] [Abstract][Full Text] [Related]
24. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice.
Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C
Vaccine; 2012 Aug; 30(40):5864-70. PubMed ID: 22814407
[TBL] [Abstract][Full Text] [Related]
25. Immunological surveys of antibodies against B. pertussis and B. parapertussis in some African and Asian countries.
Maixnerova M; Buriánová B; Teplý V; Pecenka J; Serý V; Jezek Z
J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):201-11. PubMed ID: 231624
[TBL] [Abstract][Full Text] [Related]
26. Transplacental antibodies. Part I: Maternal antibodies against B. pertussis and B. parapertussis.
Celko A; Burianová B; Maixnerová M; Stríbrný J; Zikmundová V; Zikmund V
J Hyg Epidemiol Microbiol Immunol; 1984; 28(4):465-9. PubMed ID: 6098606
[TBL] [Abstract][Full Text] [Related]
27. Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis.
Trollfors B; Lagergård T; Taranger J; Bergfors E; Schneerson R; Robbins JB
Clin Diagn Lab Immunol; 2001 Sep; 8(5):1015-7. PubMed ID: 11527820
[TBL] [Abstract][Full Text] [Related]
28. Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.
Long GH; Karanikas AT; Harvill ET; Read AF; Hudson PJ
Proc Biol Sci; 2010 Jul; 277(1690):2017-25. PubMed ID: 20200027
[TBL] [Abstract][Full Text] [Related]
29. The effectiveness of whole-cell pertussis vaccines.
Plotkin SA
Dev Biol Stand; 1997; 89():171-4. PubMed ID: 9272348
[TBL] [Abstract][Full Text] [Related]
30. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.
Khelef N; Danve B; Quentin-Millet MJ; Guiso N
Infect Immun; 1993 Feb; 61(2):486-90. PubMed ID: 8423077
[TBL] [Abstract][Full Text] [Related]
31. Human T-cell immunity against Bordetella pertussis analyzed at clonal level.
Tagliabue A; De Magistris MT; Rappuoli R
Tokai J Exp Clin Med; 1988; 13 Suppl():253-7. PubMed ID: 2908527
[TBL] [Abstract][Full Text] [Related]
32. Mixed outbreak of Bordetella pertussis and Bordetella parapertussis in an apartment house.
Iwata S; Aoyama T; Goto A; Iwai H; Sato Y; Akita H; Murase Y; Oikawa T; Iwata T; Kusano S
Dev Biol Stand; 1991; 73():333-41. PubMed ID: 1778328
[TBL] [Abstract][Full Text] [Related]
33. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
[TBL] [Abstract][Full Text] [Related]
34. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
[TBL] [Abstract][Full Text] [Related]
35. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
36. Serotype specificity of vaccine-induced immunity to pertussis.
Preston NW; Carter EJ
Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R155-6. PubMed ID: 1285135
[TBL] [Abstract][Full Text] [Related]
37. Bordetella pertussis iron regulated proteins as potential vaccine components.
Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
[TBL] [Abstract][Full Text] [Related]
38. Induction of Bordetella pertussis-specific immune memory by DTPa vaccines.
Morel S; Denoël P; Godfroid F; Cortvrindt C; Vanderheyde N; Poolman J
Vaccine; 2011 Apr; 29(18):3449-55. PubMed ID: 21382483
[TBL] [Abstract][Full Text] [Related]
39. Infection with Bordetella parapertussis but not Bordetella pertussis causes pertussis-like disease in older pigs.
Elahi S; Thompson DR; Strom S; O'Connor B; Babiuk LA; Gerdts V
J Infect Dis; 2008 Aug; 198(3):384-92. PubMed ID: 18540802
[TBL] [Abstract][Full Text] [Related]
40. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.
Asensio CJ; Gaillard ME; Moreno G; Bottero D; Zurita E; Rumbo M; van der Ley P; van der Ark A; Hozbor D
Vaccine; 2011 Feb; 29(8):1649-56. PubMed ID: 21211579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
